Updated results from a phase III trial of nivolumab (NIVO) combined with ipilimumab (IPI) in treatment-naive patients (pts) with advanced melanoma (MEL) (CheckMate 067) Meeting Abstract
| Authors: | Wolchok, J. D.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C.; Schadendorf, D.; Ferrucci, P. F.; Smylie, M.; Dummer, R.; Hill, A.; Haanen, J. B. A. G.; Maio, M.; McArthur, G. A.; Walker, D.; Jiang, J.; Horak, C. E.; Larkin, J. M. G.; Hodi, F. S. |
| Abstract Title: | Updated results from a phase III trial of nivolumab (NIVO) combined with ipilimumab (IPI) in treatment-naive patients (pts) with advanced melanoma (MEL) (CheckMate 067) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 485s |
| Language: | English |
| ACCESSION: | WOS:000404711507127 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.9505 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9505 -- Source: Wos |
